Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |